BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2877849)

  • 1. History of the development of sulphasalazine in rheumatology.
    McConkey B
    Drugs; 1986; 32 Suppl 1():12-7. PubMed ID: 2877849
    [No Abstract]   [Full Text] [Related]  

  • 2. Sulphasalazine in the long term management of rheumatoid arthritis.
    Bax DE; Amos RS
    Drugs; 1986; 32 Suppl 1():73-6. PubMed ID: 2877858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long term outcome of treatment with sulphasalazine in rheumatoid arthritis.
    Situnayake RD; McConkey B
    Drugs; 1986; 32 Suppl 1():71-2. PubMed ID: 2877857
    [No Abstract]   [Full Text] [Related]  

  • 4. [Three joints swollen, blood sedimentation increased. Methotrexate to be given immediately?].
    Burmester GR
    MMW Fortschr Med; 2004 Sep; 146(37):10. PubMed ID: 15887693
    [No Abstract]   [Full Text] [Related]  

  • 5. Symposium on enteric-coated sulphasalazine in rheumatoid arthritis. Proceedings of a symposium. London, December 6, 1985.
    Drugs; 1986; 32 Suppl 1():1-80. PubMed ID: 2877848
    [No Abstract]   [Full Text] [Related]  

  • 6. Sulphasalazine for rheumatoid arthritis. Studies on dose, acetylator phenotype and efficacy.
    Amos RS; Bax DE; Greaves MS
    Drugs; 1986; 32 Suppl 1():58. PubMed ID: 2877855
    [No Abstract]   [Full Text] [Related]  

  • 7. Sulphasalazine in rheumatoid arthritis.
    McConkey B; Amos RS; Durham S; Forster PJ; Hubball S; Walsh L
    Br Med J; 1980 Feb; 280(6212):442-4. PubMed ID: 6102877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between penicillamine and sulphasalazine in rheumatoid arthritis: Leeds-Birmingham trial.
    Neumann VC; Grindulis KA; Hubball S; McConkey B; Wright V
    Br Med J (Clin Res Ed); 1983 Oct; 287(6399):1099-102. PubMed ID: 6138116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective trial comparing the use of sulphasalazine and auranofin as second line drugs in patients with rheumatoid arthritis.
    Porter D; Madhok R; Hunter JA; Capell HA
    Ann Rheum Dis; 1992 Apr; 51(4):461-4. PubMed ID: 1350192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variables affecting efficacy and toxicity of sulphasalazine in rheumatoid arthritis. A review.
    Pullar T; Capell HA
    Drugs; 1986; 32 Suppl 1():54-7. PubMed ID: 2877854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do drugs change the course of rheumatoid arthritis?
    Wright V; Amos R
    Br Med J; 1980 Apr; 280(6219):964-6. PubMed ID: 6106520
    [No Abstract]   [Full Text] [Related]  

  • 12. 5-Aminosalicylic acid or sulphapyridine. Which is the active moiety of sulphasalazine in rheumatoid arthritis?
    Taggart AJ; Neumann VC; Hill J; Astbury C; Le Gallez P; Dixon JS
    Drugs; 1986; 32 Suppl 1():27-34. PubMed ID: 2877851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind controlled study comparing sulphasalazine with placebo in rheumatoid factor (RF)-negative rheumatoid arthritis.
    Farr M; Waterhouse L; Johnson AE; Kitas GD; Jubb RW; Bacon PA
    Clin Rheumatol; 1995 Sep; 14(5):531-6. PubMed ID: 8549091
    [No Abstract]   [Full Text] [Related]  

  • 14. Sulfasalazine in early rheumatoid arthritis. The Australian Multicentre Clinical Trial Group.
    J Rheumatol; 1992 Nov; 19(11):1672-7. PubMed ID: 1362778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies.
    Lard LR; Visser H; Speyer I; vander Horst-Bruinsma IE; Zwinderman AH; Breedveld FC; Hazes JM
    Am J Med; 2001 Oct; 111(6):446-51. PubMed ID: 11690569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulphasalazine induced three-week syndrome.
    Suresh R; Gupta S; Sathananthan R
    J Clin Rheumatol; 2009 Sep; 15(6):311-2. PubMed ID: 19734741
    [No Abstract]   [Full Text] [Related]  

  • 17. Salazopyrin in rheumatoid arthritis.
    McConkey B; Amos RS; Butler EP; Crockson RA; Crockson AP; Walsh L
    Agents Actions; 1978 Jun; 8(4):438-41. PubMed ID: 28650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulphasalazine therapy in rheumatoid arthritis: qualitative changes in lymphocytes and correlation with clinical response.
    Samanta A; Webb C; Grindulis KA; Fleming J; Sheldon PJ
    Br J Rheumatol; 1992 Apr; 31(4):259-63. PubMed ID: 1348199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulphasalazine: a safe, effective agent for prolonged control of rheumatoid arthritis. A comparison with sodium aurothiomalate.
    Bax DE; Amos RS
    Ann Rheum Dis; 1985 Mar; 44(3):194-8. PubMed ID: 2858182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New basic preparations with prolonged action in the treatment of rheumatoid arthritis].
    Tumanova IG; Sigidin IaA
    Ter Arkh; 1987; 59(4):80-3. PubMed ID: 2884735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.